Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.
about
Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidityAntibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidityAntibiotics for treating bacterial vaginosis in pregnancyProphylactic antibiotics for inhibiting preterm labour with intact membranesAntibiotics for ureaplasma in the vagina in pregnancyInterventions for trichomoniasis in pregnancyAntibiotics for treating bacterial vaginosis in pregnancyAntibiotics for ureaplasma in the vagina in pregnancyThe preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU NetworkAdvances in the Prevention of Infection-Related Preterm BirthPeriodontal Disease: A Possible Risk-Factor for Adverse Pregnancy OutcomeThe APPLe study: a randomized, community-based, placebo-controlled trial of azithromycin for the prevention of preterm birth, with meta-analysisSafety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trialIdiopathic subglottic stenosis is associated with activation of the inflammatory IL-17A/IL-23 axis.Molecular analysis of idiopathic subglottic stenosis for Mycobacterium species.Prophylactic antibiotic administration in pregnancy to prevent infectious morbidity and mortality.Antibiotics: treatment of preterm labor.Use of a continuous-culture biofilm system to study the antimicrobial susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus.Pregnancy's stronghold on the vaginal microbiomeThe effect of body mass index on therapeutic response to bacterial vaginosis in pregnancy.Evaluation of microbial enzymes in normal and abnormal cervicovaginal fluids of cervical dysplasia: a case control study.Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm deliveryLow-birthweight prevention programs: the enigma of failure.Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysisInfectious vaginitis. An accurate diagnosis is essential and attainable.Interventions for trichomoniasis in pregnancy.Bacterial vaginosis--more questions than answers.Family planning services in developing countries: an opportunity to treat asymptomatic and unrecognised genital tract infections?Cervical morphology in pregnancy, bacterial vaginosis and the risk of preterm delivery.Interpregnancy primary care and social support for African-American women at risk for recurrent very-low-birthweight delivery: a pilot evaluation.Gram-positive anaerobic cocci.Randomized controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with intrauterine infection: study protocolPrepregnancy lipids related to preterm birth risk: the coronary artery risk development in young adults study.First-trimester bleeding characteristics associate with increased risk of preterm birth: data from a prospective pregnancy cohort.Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysisBacterial vaginosis: a public health review.The fetal inflammatory response syndrome and cerebral palsy: yet another challenge and dilemma for the obstetrician.Can antibiotics prevent preterm birth--the pro and con debate.Prevention of prematurity in black and white.Sexually transmitted diseases treatment guidelines, 2015.
P2860
Q24186506-61A9B83F-2F89-4C48-887C-FE37974D9005Q24187066-B10CDD49-36D4-4979-B9A3-6BA27896F829Q24201827-C9C5D955-3A41-4E40-8AD8-78A3CCE804F4Q24201932-C4DAD7A6-4199-4D6F-9123-63C76A16D1CFQ24234256-58B59D9F-6897-45B4-B86C-CF6F1E352F32Q24234512-7708A076-754E-44F0-9D14-6361D8B3AAB2Q24246342-90612BE0-C81F-4057-AE4A-7ED5AE8DA599Q24247442-DF9904FB-D6C1-4C66-B2D8-7BB5AA0A0468Q24551159-04B5805E-49D6-4B31-98E0-68BE56B41A15Q26774686-D095A20A-A4B9-4043-B505-ABD5ED2171FDQ26801219-27A49A82-1657-469E-9AE2-3202DD80D222Q28471972-9A0774EC-9284-49D4-8EBE-8DCEA1478B5FQ28538874-BD05AD90-5FA5-4AC9-83E3-55807A21060AQ30275641-54969499-EEE6-4007-B95C-A8BEDA305429Q30276624-D4D9E46C-7CC1-461C-BD0D-12C1A37CBA1DQ30879958-ADFCD6D4-67E2-4585-A985-0EB026EC2D2DQ33644933-2DCD43E6-45AD-4CCA-A3C4-6E28F6F73E7CQ33693484-ECCB4701-0692-4E28-A0B8-93BEAE179DC3Q33711716-248ACC3E-8E2F-4526-9CD8-43AC8F71F94CQ33738804-D524C794-5DC9-4938-9936-418FEC267591Q33744709-D0C42C82-A015-454A-9D80-0BEBBC61EFD2Q33779297-89F01328-8761-4125-AD2F-3A86C61335D1Q33828418-D950FCBC-B7B9-4DE2-B192-A73E7CE07A9DQ33886845-9F646D5A-A75D-4917-AA4E-00ED393B99B9Q33897706-94DF522D-C3CA-4AEA-A31F-1FFFEAAF5CDFQ33907036-6446287D-DD72-475B-A2B2-A429D0B2DAF8Q33936847-4AE043D1-B79B-49C3-A60B-F73EBABB667BQ33937112-A3086C60-552C-4CF2-93EA-DF23859FBBF2Q33939344-F15F926B-61EB-4F74-B999-18765F9539A1Q33985450-054F1626-96BB-4493-8F36-D07348F14FB9Q33992558-66793728-52AE-41E4-93E9-DECBFB890342Q34025678-130CB42A-FB4D-45CB-84F7-0F62E93A56ECQ34032027-7553119C-1775-4556-8844-094E88097893Q34066696-C4CAA5D2-1150-44E9-AC4F-0EA05B8122AAQ34231180-2565412A-56DC-492F-815F-E34AC9E2111BQ34257760-CF861207-F27A-44C7-86F5-5AA13EB6F99BQ34308444-DDF4902D-5621-4374-B4D1-D88759F21DE6Q34395063-6F223E9C-626E-4E0D-8DEE-AF001DEE0DE3Q34404337-E764C81C-5848-422D-AB77-1E72545B9CCDQ34479272-A2D894B6-B90C-4C4A-8583-A9F767CE447E
P2860
Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Reduced incidence of preterm d ...... omen with bacterial vaginosis.
@en
Reduced incidence of preterm d ...... omen with bacterial vaginosis.
@nl
type
label
Reduced incidence of preterm d ...... omen with bacterial vaginosis.
@en
Reduced incidence of preterm d ...... omen with bacterial vaginosis.
@nl
prefLabel
Reduced incidence of preterm d ...... omen with bacterial vaginosis.
@en
Reduced incidence of preterm d ...... omen with bacterial vaginosis.
@nl
P2093
P1476
Reduced incidence of preterm d ...... omen with bacterial vaginosis.
@en
P2093
Andrews WW
Goldenberg RL
P304
P356
10.1056/NEJM199512283332603
P407
P577
1995-12-01T00:00:00Z